tffpharma.com - רווח החברה לפני מסים, ריבית ופחת TFFP
TFF Pharmaceuticals relies on third-party contractors for the synthesis of powder medications, thereby minimizing capital expenditures. The GURU.Markets platform reports the company's total operating profit, where serves as the base parameter value. The market is cautiously assessing the potential of the freeze-drying technology, maintaining a wait-and-see approach. Meanwhile, inhalation developments support environmental sustainability by reducing hazardous medical waste through the elimination of needles.
TFF Pharmaceuticals, Inc. - פילוחים אנליטיים ומדדי מפתח (TFFP)
Against the backdrop of stagnation at TFF Pharmaceuticals (TFFP) and the potential sale of patents, the consolidated EBITDA with a value of reflects the actual cash flow from core operations before taxes and interest. This indicator captures the company's actual earnings, allowing investors to avoid an illusion of stability amid rising debt loads and assess the risk of a deep asset drawdown.
